Persistent pulmonary hypertension of the newborn and maternal use of SSRIs

Wooltorton, Eric
May 2006
CMAJ: Canadian Medical Association Journal;5/23/2006, Vol. 174 Issue 11, p1555
Academic Journal
Focuses on a case study which suggested that women taking selective serotonin reuptake inhibitors in the latter half of their pregnancy may have an increased risk of their offspring developing persistent pulmonary hypertension of the newborn (PPHN). Mechanism of its action of the antidepressant drug; Brief information on PPHN.


Related Articles

  • SSRI use in late pregnancy more than doubles newborn's risk of pulmonary hypertension.  // Reactions Weekly;2/4/2012, Issue 1387, p1 

    The article reports on research which revealed that use of selective serotonin re-uptake inhibitors (SSRIs) more than doubles the risk of persistent pulmonary hypertension (PPH) in newborns.

  • SSRIs during pregnancy may cause neonatal withdrawal syndrome.  // Contemporary OB/GYN;May2005, Vol. 50 Issue 5, p18 

    Discusses research being done on selective serotonin reuptake inhibitors (SSRI) in pregnant women and neonatal syndrome. Reference to a study by E. J. Sanz, C. De-las-Cuevas, A. Kiuru et al, published in the 2005 issue of the "Lancet"; Correlation between the risks of neonatal convulsions and...

  • Changes in personality traits during treatment with sertraline or citalopram. Ekselius, Lisa; Von Knorring, Lars // British Journal of Psychiatry;May99, Vol. 174, p444 

    Background Recent studies indicate that selective serotonin re-uptake inhibitors (SSRIs) reduce the symptoms accompanying personality disorders and modulate a normal personality. Aims To examine the effect of two SSRIs, sertraline and citalopram, on personality traits in major depressed...

  • Relighting the Inner Flame. Klotter, Jule // Townsend Letter;Jan2007, Issue 282, p72 

    The article discusses the significance of selective serotonin reuptake inhibitors (SSRI) in treating mental depression in the U.S. The author discusses the withdrawal effects of the drug and argues that the drugs are necessary for the patient's health. Moreover, she emphasizes the importance of...

  • MINIMAL RISK OF BIRTH DEFECTS WITH SSRI USE.  // RN;Sep2007, Vol. 70 Issue 9, p24 

    The article discusses research being done on the association between the use of selective serotonin reuptake inhibitors (SSRI) and birth defects. It references a study by C. Louik and colleagues, published in a 2007 issue of the "New England Journal of Medicine." The study included infants with...

  • Investigating Outcomes Following the Use of Selective Serotonin Reuptake Inhibitors for Treating Depression in Pregnancy. Grzeskowiak, Luke E.; Gilbert, Andrew L.; Morrison, Janna L. // Drug Safety;2011, Vol. 34 Issue 11, p1027 

    The aim of this review was to critically appraise the existing literature with a particular focus on identifying methodological issues associated with studying outcomes following the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy. Existing studies evaluating outcomes...

  • Selective serotonin reuptake inhibitors and congenital malformations. Chambers, Christina // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/26/2009, Vol. 339 Issue 7723, p703 

    The author discusses the findings of a study conducted in Denmark in 2009 which demonstrated the link between early exposure to selective serotonin reuptake inhibitors (SSRI) and increased risk for septal heart defects. The author ponders on how the findings may aid in clinicians' and patients'...

  • Antidepressant Use Late in Pregnancy and Risk of Persistent Pulmonary Hypertension of the Newborn. Huybrechts, Krista F.; Bateman, Brian T.; Palmsten, Kristin; Desai, Rishi J.; Patorno, Elisabetta; Gopalakrishnan, Chandrasekar; Levin, Raisa; Mogun, Helen; Hernandez-Diaz, Sonia // JAMA: Journal of the American Medical Association;6/2/2015, Vol. 313 Issue 21, p2142 

    IMPORTANCE The association between selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and risk of persistent pulmonary hypertension of the newborn (PPHN) has been controversial since the US Food and Drug Administration issued a public health advisory in 2006....

  • Maternal SSRI use causes problems in newborns.  // Contemporary Pediatrics;Apr2006, Vol. 23 Issue 4, p136 

    This article presents the result of a study on the effect of prolonged exposure to selective serotonin reuptake inhibitors (SSRIs) in utero on newborns. Mother of the infants in the study took SSRIs, which includes fluoxetine, paroxetine, citalopram hydrobromide, sertraline hydrochloride and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics